Abstract for 12th international Symposium on biosafety of genetically modified organisms The identification of similarities and differences between GM plants and derived food/feed and their comparators plays a central role in risk assessment strategy. Therefore, selecting the right comparators must be one of the top priorities. The question is which control would allow us to better evaluate the potential unin...
Comunicação publicada em: Atas do Seminário "Área metropolitana de Lisboa- Ambiente Urbano e Riscos", 21 março 2012: Lisboa: Área metropolitana de Lisboa, 2013, p. 179-181. ISBN:978-972-8759-09-4. Disponível em: http://www.aml.pt/files/1913/8142/1743/livro_seminario_riscos_site.pdf
Recombinant DNA technology, also known as genetic engineering, allows the transfer of genes between unrelated species. As a result, a genetically modified organism (GMO) may contain one or more proteins coming from other organism/s. The application of genetic engineering to plants improvement and food production is becoming a common practice. New and diverse plant varieties have been obtained which are pest an...
Aula ministrada no módulo “Toxicologia e Saúde” do mestrado “Biologia Humana e Ambiente” da Faculdade de Ciências da Universidade de Lisboa (FCUL).
Projecto de Mestrado em Gestão ; Actualmente as organizações estão concentradas em satisfazer as necessidades dos clientes e se possível exceder as suas expectativas. Os clientes estão cada vez mais exigentes e requerem um serviço de excelência. O sector dos Contact Centers tem apresentado um elevado crescimento em todo o mundo, estimulado pela necessidade de prestar um serviço de qualidade ao cliente através ...
Controversy regarding genetically modified (GM) plants and their potential impact on human health contrasts with the tacit acceptance of other plants that were also modified, but not considered as GM products (e.g., varieties raised through conventional breeding such as mutagenesis). What is beyond the phenotype of these improved plants? Should mutagenized plants be treated differently from transgenics? We have...
| Financiadores do RCAAP | |||||||
|
|
|
|
|
|
||